201 related articles for article (PubMed ID: 38402619)
1. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Kastenschmidt JM; Schroers-Martin JG; Sworder BJ; Sureshchandra S; Khodadoust MS; Liu CL; Olsen M; Kurtz DM; Diehn M; Wagar LE; Alizadeh AA
Cell Stem Cell; 2024 Mar; 31(3):410-420.e4. PubMed ID: 38402619
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma: The long and winding road leading to your cure?
Gordon MJ; Smith MR; Nastoupil LJ
Blood Rev; 2023 Jan; 57():100992. PubMed ID: 35908982
[TBL] [Abstract][Full Text] [Related]
3. Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm.
Laurent C; Dietrich S; Tarte K
Blood; 2024 Mar; 143(12):1080-1090. PubMed ID: 38096368
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C; Gava F; Gravelle P; Valero JG; Dobaño-López C; Van Acker N; Quelen C; Jalowicki G; Morin R; Rossi C; Lagarde JM; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899130
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Dobaño-López C; Valero JG; Araujo-Ayala F; Nadeu F; Gava F; Faria C; Norlund M; Morin R; Bernes-Lasserre P; Arenas F; Grau M; López C; López-Oreja I; Serrat N; Martínez-Farran A; Hernández L; Playa-Albinyana H; Giménez R; Beà S; Campo E; Lagarde JM; López-Guillermo A; Magnano L; Colomer D; Bezombes C; Pérez-Galán P
Blood Cancer J; 2024 May; 14(1):75. PubMed ID: 38697976
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma microenvironment: insights provided by single-cell analysis.
Abe Y
J Clin Exp Hematop; 2023 Sep; 63(3):143-151. PubMed ID: 37635086
[TBL] [Abstract][Full Text] [Related]
7. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
Sugimoto T; Watanabe T
J Clin Exp Hematop; 2016; 56(1):1-19. PubMed ID: 27334853
[TBL] [Abstract][Full Text] [Related]
8. The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.
Watanabe T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069564
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Andor N; Simonds EF; Czerwinski DK; Chen J; Grimes SM; Wood-Bouwens C; Zheng GXY; Kubit MA; Greer S; Weiss WA; Levy R; Ji HP
Blood; 2019 Mar; 133(10):1119-1129. PubMed ID: 30591526
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Krull JE; Wenzl K; Hopper MA; Manske MK; Sarangi V; Maurer MJ; Larson MC; Mondello P; Yang Z; Novak JP; Serres M; Whitaker KR; Villasboas Bisneto JC; Habermann TM; Witzig TE; Link BK; Rimsza LM; King RL; Ansell SM; Cerhan JR; Novak AJ
Cell Rep Med; 2024 Mar; 5(3):101443. PubMed ID: 38428430
[TBL] [Abstract][Full Text] [Related]
11. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
[TBL] [Abstract][Full Text] [Related]
12. The follicular lymphoma epigenome regulates its microenvironment.
Amin R; Braza MS
J Exp Clin Cancer Res; 2022 Jan; 41(1):21. PubMed ID: 35022084
[TBL] [Abstract][Full Text] [Related]
13. B cell/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm.
Lamaison C; Tarte K
Immunol Rev; 2021 Jul; 302(1):273-285. PubMed ID: 34060097
[TBL] [Abstract][Full Text] [Related]
14. Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
Han G; Deng Q; Marques-Piubelli ML; Dai E; Dang M; Ma MCJ; Li X; Yang H; Henderson J; Kudryashova O; Meerson M; Isaev S; Kotlov N; Nomie KJ; Bagaev A; Parra ER; Solis Soto LM; Parmar S; Hagemeister FB; Ahmed S; Iyer SP; Samaniego F; Steiner R; Fayad L; Lee H; Fowler NH; Flowers CR; Strati P; Westin JR; Neelapu SS; Nastoupil LJ; Vega F; Wang L; Green MR
Blood Cancer Discov; 2022 Sep; 3(5):428-443. PubMed ID: 35687817
[TBL] [Abstract][Full Text] [Related]
15. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Araujo-Ayala F; Pérez-Galán P; Campo E
Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
[TBL] [Abstract][Full Text] [Related]
16. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
[No Abstract] [Full Text] [Related]
17. Organoid Modeling of the Tumor Immune Microenvironment.
Neal JT; Li X; Zhu J; Giangarra V; Grzeskowiak CL; Ju J; Liu IH; Chiou SH; Salahudeen AA; Smith AR; Deutsch BC; Liao L; Zemek AJ; Zhao F; Karlsson K; Schultz LM; Metzner TJ; Nadauld LD; Tseng YY; Alkhairy S; Oh C; Keskula P; Mendoza-Villanueva D; De La Vega FM; Kunz PL; Liao JC; Leppert JT; Sunwoo JB; Sabatti C; Boehm JS; Hahn WC; Zheng GXY; Davis MM; Kuo CJ
Cell; 2018 Dec; 175(7):1972-1988.e16. PubMed ID: 30550791
[TBL] [Abstract][Full Text] [Related]
18. The follicular lymphoma microenvironment: From tumor cell to host immunity.
Martinez A; Carreras J; Campo E
Curr Hematol Malig Rep; 2008 Oct; 3(4):179-86. PubMed ID: 20425464
[TBL] [Abstract][Full Text] [Related]
19. Advances in the multi-omics landscape of follicular lymphoma.
Xu T; Zheng Z; Zhao W
Int J Biol Sci; 2023; 19(6):1955-1967. PubMed ID: 37063433
[TBL] [Abstract][Full Text] [Related]
20. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
